Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
InnovAge appoints Alice Raia as chief information officer » 08:11
04/14/21
04/14
08:11
04/14/21
08:11
INNV

InnovAge

$24.20 /

+0.26 (+1.09%)

InnovAge announced that…

InnovAge announced that it has appointed Alice Raia as chief information officer, bringing "significant expertise in developing technological strategies to improve customer engagement and drive meaningful improvements to patient outcomes," the company said. In this role, Raia will lead InnovAge's strategy and development for data management, digital technologies integration, information technologies and technical transformation. Raia brings to InnovAge more than 25 years of healthcare and technology experience, most recently as vice president - digital experience engineering at Kaiser Permanente in California.

ShowHide Related Items >><<
INNV InnovAge
$24.20 /

+0.26 (+1.09%)

04/01/21 Piper Sandler
American Jobs Plan could strengthen backdrop for InnovAge, says Piper Sandler
03/29/21
Fly Intel: Top five analyst initiations
03/29/21 William Blair
InnovAge initiated with an Outperform at William Blair
03/29/21 Barclays
InnovAge initiated with an Equal Weight at Barclays
  • 04
    Mar
INNV InnovAge
$24.20 /

+0.26 (+1.09%)

INNV InnovAge
$24.20 /

+0.26 (+1.09%)

Over a week ago
Recommendations
American Jobs Plan could strengthen backdrop for InnovAge, says Piper Sandler » 14:38
04/01/21
04/01
14:38
04/01/21
14:38
INNV

InnovAge

$24.64 /

-1.22 (-4.72%)

Piper Sandler analyst…

Piper Sandler analyst Chris Neamonitis believes the proposed American Jobs Plan, with likely support in the House, could strengthen the already-strong backdrop for InnovAge. While details remain light and the analyst doesn't see any immediate InnovAge impact, Neamonitis argues that the plan calls out a commitment to caregiving jobs and the easiest option for states would be to engage with InnovAge as a partner to grow HCBS via PACE, MFP. The analyst is a buyer of the stock on a strong runway that supports sustainable growth. He has an Overweight rating and a price target of $31 on the shares.

ShowHide Related Items >><<
INNV InnovAge
$24.64 /

-1.22 (-4.72%)

03/29/21
Fly Intel: Top five analyst initiations
03/29/21 William Blair
InnovAge initiated with an Outperform at William Blair
03/29/21 Barclays
InnovAge initiated with an Equal Weight at Barclays
03/29/21 Citi
InnovAge initiated with a Buy at Citi
  • 04
    Mar
INNV InnovAge
$24.64 /

-1.22 (-4.72%)

INNV InnovAge
$24.64 /

-1.22 (-4.72%)

Periodicals
Former InnovAge employees express concerns over patient care, Capitol Forum says » 08:49
03/31/21
03/31
08:49
03/31/21
08:49
INNV

InnovAge

$24.00 /

-0.09 (-0.37%)

Former InnovAge employees…

Former InnovAge employees tell The Capitol Forum that the company enrolled patients with healthcare needs beyond its capabilities in order to collect payments under a federal program and increase revenue, the news service stated in a report available to its subscribers. Reference Link

ShowHide Related Items >><<
INNV InnovAge
$24.00 /

-0.09 (-0.37%)

03/29/21
Fly Intel: Top five analyst initiations
03/29/21 William Blair
InnovAge initiated with an Outperform at William Blair
03/29/21 Barclays
InnovAge initiated with an Equal Weight at Barclays
03/29/21 Citi
InnovAge initiated with a Buy at Citi
  • 04
    Mar
INNV InnovAge
$24.00 /

-0.09 (-0.37%)

Initiation
Fly Intel: Top five analyst initiations » 09:54
03/29/21
03/29
09:54
03/29/21
09:54
INNV

InnovAge

$24.80 /

+0.64 (+2.65%)

, OSCR

Oscar Health

$25.98 /

+0.295 (+1.15%)

, CTMX

CytomX Therapeutics

$7.89 /

+0.27 (+3.54%)

, FRO

Frontline

$7.55 /

-0.54 (-6.67%)

, CREE

Cree

$106.16 /

-1.38 (-1.28%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. InnovAge (INNV) initiated with a Buy at Goldman Sachs and Citi, initiated with an Overweight at Piper Sandler, initiated with an Equal Weight at Barclays and initiated with an Outperform at William Blair. 2. Oscar Health (OSCR) initiated with a Buy at Goldman Sachs, initiated with a Market Perform at Cowen, initiated with an Overweight at Morgan Stanley and initiated with a Buy at BofA. 3. CytomX Therapeutics (CTMX) initiated with an Overweight at JPMorgan. 4. Frontline (FRO) initiated with a Neutral at H.C. Wainwright. 5. Cree (CREE) initiated with a Buy at New Street. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
FRO Frontline
$7.55 /

-0.54 (-6.67%)

CTMX CytomX Therapeutics
$7.89 /

+0.27 (+3.54%)

CREE Cree
$106.16 /

-1.38 (-1.28%)

INNV InnovAge
$24.80 /

+0.64 (+2.65%)

03/29/21 William Blair
InnovAge initiated with an Outperform at William Blair
03/29/21 Barclays
InnovAge initiated with an Equal Weight at Barclays
03/29/21 Citi
InnovAge initiated with a Buy at Citi
03/29/21 Goldman Sachs
InnovAge initiated with a Buy at Goldman Sachs
OSCR Oscar Health
$25.98 /

+0.295 (+1.15%)

03/29/21 BofA
Oscar Health initiated with a Buy at BofA
03/29/21 Morgan Stanley
Oscar Health initiated with an Overweight at Morgan Stanley
03/29/21 Cowen
Oscar Health initiated with a Market Perform at Cowen
03/29/21 Credit Suisse
Oscar Health initiated with an Outperform at Credit Suisse
CTMX CytomX Therapeutics
$7.89 /

+0.27 (+3.54%)

03/29/21 JPMorgan
CytomX Therapeutics initiated with an Overweight at JPMorgan
03/23/21 Jefferies
CytomX Therapeutics upgraded to Buy from Hold at Jefferies
09/22/20 Guggenheim
Guggenheim taking more conservative view, downgrades CytomX to Neutral
09/22/20 Guggenheim
CytomX Therapeutics downgraded to Neutral from Buy at Guggenheim
FRO Frontline
$7.55 /

-0.54 (-6.67%)

03/29/21 H.C. Wainwright
Frontline initiated with a Neutral at H.C. Wainwright
02/22/21
Fly Intel: Top five analyst downgrades
02/22/21 Jefferies
Frontline downgraded to Hold on valuation after earnings miss at Jefferies
02/22/21 Jefferies
Frontline downgraded to Hold from Buy at Jefferies
CREE Cree
$106.16 /

-1.38 (-1.28%)

03/29/21 New Street
New Street starts 'silicon carbide pure play' Cree with Buy, $120 target
03/29/21 New Street
Cree initiated with a Buy at New Street
03/01/21 BofA
Cree initiated with a Buy at BofA
02/22/21 Cowen
Cowen upgrades Cree on underappreciated device platform
FRO Frontline
$7.55 /

-0.54 (-6.67%)

CTMX CytomX Therapeutics
$7.89 /

+0.27 (+3.54%)

CREE Cree
$106.16 /

-1.38 (-1.28%)

  • 04
    Mar
  • 03
    Mar
  • 21
    Jan
OSCR Oscar Health
$25.98 /

+0.295 (+1.15%)

INNV InnovAge
$24.80 /

+0.64 (+2.65%)

CTMX CytomX Therapeutics
$7.89 /

+0.27 (+3.54%)

CREE Cree
$106.16 /

-1.38 (-1.28%)

OSCR Oscar Health
$25.98 /

+0.295 (+1.15%)

FRO Frontline
$7.55 /

-0.54 (-6.67%)

CREE Cree
$106.16 /

-1.38 (-1.28%)

Initiation
InnovAge initiated with an Outperform at William Blair » 07:17
03/29/21
03/29
07:17
03/29/21
07:17
INNV

InnovAge

$24.48 /

+0.29 (+1.20%)

William Blair analyst…

William Blair analyst Matt Larew initiated coverage of InnovAge with an Outperform rating and no price target. With a focus on high-cost, high-risk dual eligible patients, InnovAge stands to benefit from accelerating underlying demographic demand in the elderly population and continued adoption of capitated care delivery models to manage chronic conditions safely and effectively in the home and community, Larew tells investors in a research note. The analyst sees a "clear roadmap" to 20%-plus long-term growth.

ShowHide Related Items >><<
INNV InnovAge
$24.48 /

+0.29 (+1.20%)

03/29/21 Barclays
InnovAge initiated with an Equal Weight at Barclays
03/29/21 Citi
InnovAge initiated with a Buy at Citi
03/29/21 Goldman Sachs
InnovAge initiated with a Buy at Goldman Sachs
03/29/21 Piper Sandler
InnovAge initiated with an Overweight at Piper Sandler
  • 04
    Mar
INNV InnovAge
$24.48 /

+0.29 (+1.20%)

Initiation
InnovAge initiated with an Equal Weight at Barclays » 06:34
03/29/21
03/29
06:34
03/29/21
06:34
INNV

InnovAge

$24.48 /

+0.29 (+1.20%)

Barclays analyst Steve…

Barclays analyst Steve Valiquette initiated coverage of InnovAge with an Equal Weight rating.

ShowHide Related Items >><<
INNV InnovAge
$24.48 /

+0.29 (+1.20%)

03/29/21 Citi
InnovAge initiated with a Buy at Citi
03/29/21 Goldman Sachs
InnovAge initiated with a Buy at Goldman Sachs
03/29/21 Piper Sandler
InnovAge initiated with an Overweight at Piper Sandler
  • 04
    Mar
INNV InnovAge
$24.48 /

+0.29 (+1.20%)

Initiation
InnovAge initiated with a Buy at Citi » 06:25
03/29/21
03/29
06:25
03/29/21
06:25
INNV

InnovAge

$24.48 /

+0.29 (+1.20%)

Citi analyst Ralph…

Citi analyst Ralph Giacobbe initiated coverage of InnovAge with a Buy rating and $30 price target. The company is a provider-based entity treating and managing care for high-cost, frail, and elderly individuals in a capitated value-based care model, Giacobbe tells investors in a research note. The analyst sees "significant opportunities for growth" via InnovAge's existing centers and through de novo, acquisitions and geographic expansion.

ShowHide Related Items >><<
INNV InnovAge
$24.48 /

+0.29 (+1.20%)

03/29/21 Goldman Sachs
InnovAge initiated with a Buy at Goldman Sachs
03/29/21 Piper Sandler
InnovAge initiated with an Overweight at Piper Sandler
  • 04
    Mar
INNV InnovAge
$24.48 /

+0.29 (+1.20%)

Initiation
InnovAge initiated with a Buy at Goldman Sachs » 04:57
03/29/21
03/29
04:57
03/29/21
04:57
INNV

InnovAge

$24.48 /

+0.29 (+1.20%)

Goldman Sachs analyst…

Goldman Sachs analyst Jamie Perse initiated coverage of InnovAge with a Buy rating and $32 price target. The analyst views the company as a "unique value-based care asset" that is well positioned in a relatively small but growing end-market, with limited direct competition. The program of all-inclusive care for the elderly market in which InnovAge participates is still "significantly underpenetrated" at just 3% of total addressable market, with opportunities for market expansion in both current and future geographies, Perse tells investors in a research note.

ShowHide Related Items >><<
INNV InnovAge
$24.48 /

+0.29 (+1.20%)

03/29/21 Piper Sandler
InnovAge initiated with an Overweight at Piper Sandler
  • 04
    Mar
INNV InnovAge
$24.48 /

+0.29 (+1.20%)

Initiation
InnovAge initiated with an Overweight at Piper Sandler » 04:53
03/29/21
03/29
04:53
03/29/21
04:53
INNV

InnovAge

$24.48 /

+0.29 (+1.20%)

Piper Sandler analyst…

Piper Sandler analyst Chris Neamonitis initiated coverage of InnovAge with an Overweight rating and $31 price target. InnovAge represents an "aligned integration" of Medicare and Medicaid resources, and has embraced being a "payvider" long before trend emergence, Neamonitis tells investors in a research note. The analyst sees "meaningful opportunity" for InnovAge to broaden the scope of the populations that it serves.

ShowHide Related Items >><<
  • 04
    Mar
INNV InnovAge
$24.48 /

+0.29 (+1.20%)

Over a month ago
On The Fly
Opening Day: InnovAge rises, Oscar Health slips on first trading day » 09:14
03/07/21
03/07
09:14
03/07/21
09:14
INNV

InnovAge

$25.16 /

+1 (+4.14%)

, OSCR

Oscar Health

$31.01 /

-1.02 (-3.19%)

, VPCC

VPC Impact Acquisition Holdings III

$0.00 /

+ (+0.00%)

, VPCB

VPC Impact Acquisition Holdings II

$0.00 /

+ (+0.00%)

, WPCA

Warburg Pincus Capital Corporation I-A

$0.00 /

+ (+0.00%)

, ATVC

Tribe Capital Growth Corp I

$0.00 /

+ (+0.00%)

, WPCB

Warburg Pincus Capital Corporation I-B

$0.00 /

+ (+0.00%)

, DMYQ

dMY Technology Group IV

$0.00 /

+ (+0.00%)

, TWNT

Tailwind Two Acquisition

$0.00 /

+ (+0.00%)

, FRSG

First Reserve Sustainable Growth

$0.00 /

+ (+0.00%)

, IPVI

InterPrivate IV InfraTech Partners

$0.00 /

+ (+0.00%)

, IPVF

InterPrivate III Financial Partners

$0.00 /

+ (+0.00%)

, IPVA

InterPrivate II Acquisition

$0.00 /

+ (+0.00%)

, PSAGU

Property Solutions Acquisition II

$10.00 /

+0.04 (+0.40%)

, KVSA

Khosla Ventures Acquisition

$10.69 /

+0.43 (+4.19%)

, AURC

Aurora Acquisition

$0.00 /

+ (+0.00%)

, ATAQ

Altimar Acquisition Corp. III

$0.00 /

+ (+0.00%)

, TRCA

Twin Ridge Capital Acquisition

$0.00 /

+ (+0.00%)

, ISOS

Isos Acquisition

$0.00 /

+ (+0.00%)

, MACC

Mission Advancement

$0.00 /

+ (+0.00%)

, ROCR

Roth CH Acquisition III

$0.00 /

+ (+0.00%)

, DHBC

DHB Capital

$0.00 /

+ (+0.00%)

, GBRG

Goldenbridge Acquisition

$0.00 /

+ (+0.00%)

, TSPQ

TCW Special Purpose Acquisition

$0.00 /

+ (+0.00%)

, FTEV

FinTech Evolution Acquisition

$0.00 /

+ (+0.00%)

, SNII

Supernova Partners Acquisition II

$0.00 /

+ (+0.00%)

, OPHA

Orion Acquisition

$0.00 /

+ (+0.00%)

, NDAC

NightDragon Acquisition

$0.00 /

+ (+0.00%)

, ANZU

Anzu Special Acquisition Corp I

$0.00 /

+ (+0.00%)

, NSTD

Northern Star Investment Corp. IV

$0.00 /

+ (+0.00%)

, NSTC

Northern Star Investment Corp. III

$0.00 /

+ (+0.00%)

, LOKM

Live Oak Mobility Acquisition

$0.00 /

+ (+0.00%)

, AMPI

Advanced Merger Partners

$0.00 /

+ (+0.00%)

, COIN

Coinbase

$0.00 /

+ (+0.00%)

, RBLX

Roblox

$0.00 /

+ (+0.00%)

, VZIO

Vizio

$0.00 /

+ (+0.00%)

, GROY

Gold Royalty

$0.00 /

+ (+0.00%)

, ALHC

Alignment Healthcare

$0.00 /

+ (+0.00%)

, HOOD

Robinhood

$0.00 /

+ (+0.00%)

, PLTR

Palantir

$23.92 /

-0.83 (-3.35%)

, ASAN

Asana

$30.61 /

-0.04 (-0.13%)

, WORK

Slack Technologies

$40.44 /

+0.465 (+1.16%)

, SPOT

Spotify

$274.70 /

-10.14 (-3.56%)

, BABA

Alibaba

$233.65 /

+3.575 (+1.55%)

Elder-care company…

ShowHide Related Items >><<
WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

SPOT Spotify
$274.70 /

-10.14 (-3.56%)

RBLX Roblox
$0.00 /

+ (+0.00%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

HOOD Robinhood
$0.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BABA Alibaba
$233.65 /

+3.575 (+1.55%)

ASAN Asana
$30.61 /

-0.04 (-0.13%)

INNV InnovAge
$25.16 /

+1 (+4.14%)

OSCR Oscar Health
$31.01 /

-1.02 (-3.19%)

VPCC VPC Impact Acquisition Holdings III
$0.00 /

+ (+0.00%)

VPCB VPC Impact Acquisition Holdings II
$0.00 /

+ (+0.00%)

WPCA Warburg Pincus Capital Corporation I-A
$0.00 /

+ (+0.00%)

ATVC Tribe Capital Growth Corp I
$0.00 /

+ (+0.00%)

WPCB Warburg Pincus Capital Corporation I-B
$0.00 /

+ (+0.00%)

DMYQ dMY Technology Group IV
$0.00 /

+ (+0.00%)

TWNT Tailwind Two Acquisition
$0.00 /

+ (+0.00%)

FRSG First Reserve Sustainable Growth
$0.00 /

+ (+0.00%)

IPVI InterPrivate IV InfraTech Partners
$0.00 /

+ (+0.00%)

IPVF InterPrivate III Financial Partners
$0.00 /

+ (+0.00%)

IPVA InterPrivate II Acquisition
$0.00 /

+ (+0.00%)

PSAGU Property Solutions Acquisition II
$10.00 /

+0.04 (+0.40%)

KVSA Khosla Ventures Acquisition
$10.69 /

+0.43 (+4.19%)

AURC Aurora Acquisition
$0.00 /

+ (+0.00%)

ATAQ Altimar Acquisition Corp. III
$0.00 /

+ (+0.00%)

TRCA Twin Ridge Capital Acquisition
$0.00 /

+ (+0.00%)

ISOS Isos Acquisition
$0.00 /

+ (+0.00%)

MACC Mission Advancement
$0.00 /

+ (+0.00%)

ROCR Roth CH Acquisition III
$0.00 /

+ (+0.00%)

DHBC DHB Capital
$0.00 /

+ (+0.00%)

GBRG Goldenbridge Acquisition
$0.00 /

+ (+0.00%)

TSPQ TCW Special Purpose Acquisition
$0.00 /

+ (+0.00%)

FTEV FinTech Evolution Acquisition
$0.00 /

+ (+0.00%)

SNII Supernova Partners Acquisition II
$0.00 /

+ (+0.00%)

OPHA Orion Acquisition
$0.00 /

+ (+0.00%)

NDAC NightDragon Acquisition
$0.00 /

+ (+0.00%)

ANZU Anzu Special Acquisition Corp I
$0.00 /

+ (+0.00%)

NSTD Northern Star Investment Corp. IV
$0.00 /

+ (+0.00%)

NSTC Northern Star Investment Corp. III
$0.00 /

+ (+0.00%)

LOKM Live Oak Mobility Acquisition
$0.00 /

+ (+0.00%)

AMPI Advanced Merger Partners
$0.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 DA Davidson
Coinbase initiated with a Buy at DA Davidson
RBLX Roblox
$0.00 /

+ (+0.00%)

VZIO Vizio
$0.00 /

+ (+0.00%)

GROY Gold Royalty
$0.00 /

+ (+0.00%)

ALHC Alignment Healthcare
$0.00 /

+ (+0.00%)

HOOD Robinhood
$0.00 /

+ (+0.00%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

02/17/21
Fly Intel: Top five analyst upgrades
02/17/21 RBC Capital
Palantir price target raised to $27 from $15 at RBC Capital
02/17/21 Jefferies
Palantir 'a highly unique story for long-term investors,' says Jefferies
02/17/21 Morgan Stanley
Palantir price target raised to $19 from $17 at Morgan Stanley
ASAN Asana
$30.61 /

-0.04 (-0.13%)

03/05/21
Fly Intel: Top five analyst initiations
03/05/21 Baird
Asana initiated with an Outperform, $40 price target at Baird
03/04/21 Baird
Asana initiated with an Outperform at Baird
01/15/21 Credit Suisse
Asana assumed with a Neutral at Credit Suisse
WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

03/05/21 DA Davidson
Slack Technologies price target lowered to $40 from $46 at DA Davidson
12/09/20 Morgan Stanley
Salesforce $50B revenue target unlikely a source of upside, says Morgan Stanley
12/09/20 Canaccord
Salesforce valuation compelling especially on pullback, says Canaccord
12/09/20 Morgan Stanley
Slack Technologies upgraded to Equal Weight from Underweight at Morgan Stanley
SPOT Spotify
$274.70 /

-10.14 (-3.56%)

02/23/21
Fly Intel: Top five analyst downgrades
02/23/21 JPMorgan
Spotify price target raised to $385 from $350 at JPMorgan
02/23/21 Atlantic Equities
Spotify downgraded to Neutral from Overweight at Atlantic Equities
02/10/21 Pivotal Research
Spotify price target raised to $340 from $260 at Pivotal Research
BABA Alibaba
$233.65 /

+3.575 (+1.55%)

02/23/21 Credit Suisse
Farfetch price target raised to $85 from $53 at Credit Suisse
02/03/21 Raymond James
Alibaba price target raised to $350 from $330 at Raymond James
02/03/21 Mizuho
Alibaba price target raised to $285 from $270 at Mizuho
02/03/21 Macquarie
Alibaba price target raised to $395 from $387 at Macquarie
WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

SPOT Spotify
$274.70 /

-10.14 (-3.56%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

BABA Alibaba
$233.65 /

+3.575 (+1.55%)

ASAN Asana
$30.61 /

-0.04 (-0.13%)

  • 09
    Mar
  • 04
    Mar
  • 03
    Mar
WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

SPOT Spotify
$274.70 /

-10.14 (-3.56%)

RBLX Roblox
$0.00 /

+ (+0.00%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

HOOD Robinhood
$0.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BABA Alibaba
$233.65 /

+3.575 (+1.55%)

ASAN Asana
$30.61 /

-0.04 (-0.13%)

WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

VZIO Vizio
$0.00 /

+ (+0.00%)

SPOT Spotify
$274.70 /

-10.14 (-3.56%)

RBLX Roblox
$0.00 /

+ (+0.00%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

OSCR Oscar Health
$31.01 /

-1.02 (-3.19%)

HOOD Robinhood
$0.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BABA Alibaba
$233.65 /

+3.575 (+1.55%)

ASAN Asana
$30.61 /

-0.04 (-0.13%)

WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

SPOT Spotify
$274.70 /

-10.14 (-3.56%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

BABA Alibaba
$233.65 /

+3.575 (+1.55%)

ASAN Asana
$30.61 /

-0.04 (-0.13%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.